CN Patent
CN116547007A — 放射性药物和方法
Assigned to Pu'an Biopharmaceutical Co ltd · Expires 2023-08-04 · 3y expired
What this patent protects
提供放射性药物 177 Lu‑PSMAI&T,包括具有延长保存期内的高纯度。进一步提供了 177 Lu‑PSMAI&T的合成方法以及包含 177 Lu‑PSMAI&T的药物组合物和治疗方法。
USPTO Abstract
提供放射性药物 177 Lu‑PSMAI&T,包括具有延长保存期内的高纯度。进一步提供了 177 Lu‑PSMAI&T的合成方法以及包含 177 Lu‑PSMAI&T的药物组合物和治疗方法。
Drugs covered by this patent
- lutetium-lu-177-dotatate (Lutetium Lu 177 Dotatate) · National Cancer Institute (NCI)
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.